Lung Cancer
Conference Coverage
Managing cancer outpatients during the pandemic: Tips from MSKCC
MSKCC has established guiding principles on how to manage cancer patients during the pandemic.
Conference Coverage
Death rates ‘remain high’ in patients with thoracic cancers and COVID-19
The risk of death was similar across racial and ethnic groups.
Conference Coverage
Nivolumab improves survival in relapsed mesothelioma
Nivolumab prolonged progression-free and overall survival, compared with placebo.
Conference Coverage
Screening for lung cancer in never-smokers is ‘feasible’
Never-smokers should be screened for lung cancer too, researchers say.
Conference Coverage
‘Astonishing’ 4-year survival in NSCLC with pembro plus chemo
New data showing a doubling in survival with the combination versus chemo alone have been hailed as “very impressive” by clinicians.
Conference Coverage
Pandemic seems to impact lung cancer diagnosis and prognosis
There was a 38% decrease in new lung cancer diagnoses during the pandemic, and 30-day mortality rates nearly doubled.
Article
COVID-19 vaccination in cancer patients: NCCN outlines priorities
Recommended timing of vaccination varies based on cancer and treatment type.
Conference Coverage
AI can identify biomarkers and potentially guide therapy in NSCLC
Deep learning models accurately predicted PD-L1 positivity and EGFR mutational status in patients with non–small cell lung cancer.
News
Lung disease raises mortality risk in older RA patients
Presence of RA-associated interstitial lung disease was associated with increased total, respiratory, and cancer mortality.
News
Lung cancer screening during pandemic: Paused, then rebounded across patient subgroups
An analysis finds similar declines and rebounds in screening among Whites and non-Whites.